Jessica A. Campbell, PhD Pfizer

Jessica Campbell received her PhD in immunology from Washington University in St. Louis in 2009, where she studied mechanisms of viral immune evasion. Following postdoctoral fellowships at Washington University and Pfizer, she joined the Bioassay and Impurity Testing group within the Analytical Research and Development organization at Pfizer in 2015, where she initially focused on development of host cell protein immunoassays and the monocyte activation test (MAT). She currently leads an analytical group that manages the MAT and assays used for the detection of process-related impurities.